Log in to your Inderes Free account to see all free content on this page.
Coegin Pharma
4.25 SEK
-0.93 %
Less than 1K followers
COEGIN
Nordic SME
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-0.93 %
-4.28 %
-11.46 %
-38.23 %
+26.49 %
-7.61 %
-63.75 %
-77.15 %
-86.64 %
Coegin Pharma is a Swedish biotechnology company in commercial phase, developing science-based innovations for hair and skin. The company's patented ingredient for hair growth is now available in products sold through selected partners. A peptide for natural skin pigmentation is also in development with a planned launch in the near future. Coegin Pharma is headquartered in Lund.
Read moreMarket cap
105.73M SEK
Turnover
27.95K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
26.2.
2026
Annual report '25
21.5.
2026
Interim report Q1'26
21.5.
2026
General meeting '26
All
Press releases
ShowingAll content types
Coegin Pharma appoints worldleading pigmentation and hair-biology expert Professor Desmond J. Tobin as Scientific Advisor
Coegin Pharma completes first delivery of Follicopeptide products to Hårklinikken
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio